Know Cancer

or
forgot password
  • cancer clinical trials in des moines, IA

  • Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    John Stoddard Cancer Center at Iowa Methodist Medical Center

    Trial Locations
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Head and Neck Cancer, Precancerous Condition
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Breast Cancer
    Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
    John Stoddard Cancer Center at Iowa Methodist Medical Center

    Trial Locations
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Cervical Cancer, Endometrial Cancer, Sarcoma
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Cervical Cancer
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Lung Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Kidney Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Breast Cancer
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Medical Oncology and Hematology Associates
    Des Moines, Iowa 50309
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer